EDITORIAL
Published on 26 Aug 2022
Editorial: Updates on convalescent plasma and monoclonal antibody therapies for infectious disease in patients with primary immunodeficiency
doi 10.3389/fimmu.2022.1010072
- 633 views
- Frontiers in Immunology
- Primary Immunodeficiencies
- Research Topics
- Updates on Convalescent Plasma and Monoclonal Antibody Therapies for Infectious Disease in Patients with Primary Immunodeficiency
Updates on Convalescent Plasma and Monoclonal Antibody Therapies for Infectious Disease in Patients with Primary Immunodeficiency
3,499
Total downloads
11k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 28 Jul 2022
Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic
doi 10.3389/fimmu.2022.947174
- 2,293 views
- 10 citations
CASE REPORT
Published on 21 Jun 2022
Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment
doi 10.3389/fimmu.2022.891274
- 2,350 views
- 5 citations
ORIGINAL RESEARCH
Published on 16 Jun 2022
The Efficiency of Convalescent Plasma Therapy in the Management of Critically Ill Patients Infected With COVID-19: A Matched Cohort Study
doi 10.3389/fmed.2022.822821
- 1,266 views
- 7 citations
CASE REPORT
Published on 03 May 2021
Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure
doi 10.3389/fimmu.2021.645989
- 3,001 views
- 11 citations
